SEP 08,2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Liquid Biopsy Market.

Liquid Biopsy Market size is expected to grow at a strong CAGR during the next five years

According to a report published by The World Health Organization in 2017, the number of breast cancer deaths around the globe is expected to increase. By 2040, more than 991,000 women are expected to die annually of breast cancer across the globe.

Market Insights The potential for liquid biopsies to lead to early detection of cancer may impact several product lines, mainly critical illness (CI) and medical insurance. Over the past few years, CI has undergone several innovations. Companies now offer staged, multi-pay, and cancer-only plans. A unique selling point of cancer-only and staged CI plans is they cover early-stage cancers as well. Increased near-term utilization of liquid biopsy as part of routine screening tests or diagnostic protocols could lead to higher cancer incidence rates than anticipated. This could impact the pricing assumptions of certain products, especially those offering early-stage cancer benefits.

Recent mainstream news flow has made much of the CancerSEEK diagnostic test, particularly its ability to detect multiple types of cancer from a single blood sample. In reality, further confirmatory tests will be required post-screening before a patient is placed on the current standard of care for their particular cancer. Also, the test’s sensitivity falls to 70% for the purposes of screening certain cancers, which is insufficient to drive standalone clinical decisions. Therefore, considerable further development and validation of liquid biopsy-type platforms are required to establish such a ‘one stop’ diagnostic test. Among the key competitors in liquid biopsy, Biocept, Oncocyte and few others are creating buzz in the market.

Overall, the liquid biopsy (LB) concept complements the personalized medicine approach and provides an innovative way for patient selection in clinical trials, here mutational analysis supports patient eligibility for targeted therapy.

Liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, mainly blood. This technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with an added benefit of being largely non-invasive.

This report studies the global liquid biopsy market size over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the liquidy biopsy market size, trends, forecasts, and dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

Features of the Report This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The Liquid Biopsy Market analysis report discusses the following heads in great detail: • Market structure: Overview, industry life cycle analysis, supply chain analysis • COVID-19 Impact Assessment • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis • Market trend and forecast analysis • Market segment trend and forecast • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc. • Attractive market segments and associated growth opportunities • Emerging trends • Strategic growth opportunities for the existing and new players • Key success factors

Customization of the Report: This report can be customized to meet the client’s requirements. In order to provide more accurate market forecast, all the reports are updated before delivery. You can mail our sales team at (sales@stratviewresearch.com) and get in touch with us on +1-313-307-4176 to share your research requirements.

About Us: Stratview Research is a trusted global market intelligence and strategic consulting firm providing inclusive range of services to multiple clients across a wide array of industries. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.